Literature DB >> 3887557

Characterization of two murine monoclonal antibodies reactive with human B cells. Their use in a high-yield, high-purity method for isolation of B cells and utilization of such cells in an assay for B-cell stimulating factor.

E Smeland, S Funderud, E Ruud, H Kiil Blomhoff, T Godal.   

Abstract

We describe two monoclonal antibodies, HH1 and HH2. Both reacted selectively with surface immunoglobulin (sIg)-positive human B cells. Both antibodies stained on average 7-8% of peripheral blood mononuclear cells. They have not been found to react with cells or cell lines of other haematopoietic cell lineages, except that HH2 was positive on a small percentage of cells of the erythroid cell line K562. The molecular weight of the HH1 antigen was 95 kD, as established by Western blotting. Neither of these two antibodies reacted with Ig determinants, Fc receptors, complement receptors, or known class-I or class-II molecules. A combination of these antibodies was used in a direct panning technique for high-yield enrichment of normal B lymphocytes from peripheral blood. The enriched B cells could be further purified by lysis of T cells (final yield, on average 72 +/- 8% of initial B cells) or by a second panning (yield, 35 +/- 11%). The purified B cells contained less than 1% contaminating T cells and less than 0.5% monocytes and were used in an assay for B-cell-stimulating factor which they showed a normal and very reproducible proliferative response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3887557     DOI: 10.1111/j.1365-3083.1985.tb01422.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  13 in total

1.  The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2,6-sialyltransferase.

Authors:  B J Bast; L J Zhou; G J Freeman; K J Colley; T J Ernst; J M Munro; T F Tedder
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

2.  Expression of the CDw75 (beta-galactoside alpha 2,6-sialyltransferase) antigen on normal blood cells and in B-cell chronic lymphocytic leukaemia.

Authors:  K Guy; J M Andrew
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

3.  Direct immunomagnetic quantification of lymphocyte subsets in blood.

Authors:  J E Brinchmann; F Vartdal; G Gaudernack; G Markussen; S Funderud; J Ugelstad; E Thorsby
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

4.  Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma.

Authors:  Hakan Köksal; Pierre Dillard; Sarah E Josefsson; Solrun Melkorka Maggadottir; Sylvie Pollmann; Anne Fåne; Yngvild Nuvin Blaker; Klaus Beiske; Kanutte Huse; Arne Kolstad; Harald Holte; Gunnar Kvalheim; Erlend B Smeland; June H Myklebust; Else Marit Inderberg; Sébastien Wälchli
Journal:  Blood Adv       Date:  2019-04-23

5.  Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude mice.

Authors:  F Gärtner; L David; R Seruca; J C Machado; M Sobrinho-Simões
Journal:  Virchows Arch       Date:  1996-05       Impact factor: 4.064

6.  Monoclonal antibodies EBU-141 (CDw75) and EBU-65 allow reliable distinction between mature and pre-B-cell tumors in suspension and on tissue sections.

Authors:  M Gramatzki; R Burger; J Kraus; U Lauer; P Rohwer; G Eger; J R Kalden; F Henschke
Journal:  Ann Hematol       Date:  1991-07       Impact factor: 3.673

7.  The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate.

Authors:  E Smeland; T Godal; E Ruud; K Beiske; S Funderud; E A Clark; S Pfeifer-Ohlsson; R Ohlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Induction of IgM secretion by chronic B-lymphocytic leukaemia cells in serum-free medium: effects of interferon-alpha, -gamma and phorbol ester.

Authors:  T H Tötterman; M Carlsson; K Nilsson
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

9.  177Lu-DOTA-HH1, a novel anti-CD37 radio-immunoconjugate: a study of toxicity in nude mice.

Authors:  Ada H V Repetto-Llamazares; Roy H Larsen; Anna Maria Giusti; Elena Riccardi; Øyvind S Bruland; Pål Kristian Selbo; Jostein Dahle
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

10.  Biodistribution and dosimetry of (177)Lu-tetulomab, a new radioimmunoconjugate for treatment of non-Hodgkin lymphoma.

Authors:  Ada H V Repetto-Llamazares; Roy H Larsen; Camilla Mollatt; Michael Lassmann; Jostein Dahle
Journal:  Curr Radiopharm       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.